Page last updated: 2024-12-08

(sulfobromophthalein)glutathione conjugate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

## (Sulfobromophthalein)glutathione conjugate: A key player in drug metabolism and research

**(Sulfobromophthalein)glutathione conjugate** (BSP-GSH) is a compound formed when **sulfobromophthalein** (BSP), a dye commonly used in medical research, reacts with **glutathione** (GSH), a small molecule with antioxidant properties. This conjugation reaction is a vital process in the liver's detoxification system.

**Why is BSP-GSH important for research?**

1. **Indicator of hepatic function:**
- BSP is taken up by the liver and processed through several enzymatic reactions, eventually forming BSP-GSH.
- The rate of this conjugation process is directly correlated with the liver's ability to detoxify substances.
- Measuring BSP-GSH levels in blood can therefore provide a sensitive indicator of liver function, particularly in situations like liver disease or drug toxicity.

2. **Model for drug metabolism:**
- BSP is a good model substrate for studying the liver's drug metabolism processes.
- Understanding how BSP is metabolized and conjugated to GSH helps researchers understand how other drugs are handled by the liver.
- This knowledge is crucial for drug development, enabling researchers to predict potential toxicity and optimize drug efficacy.

3. **Investigating glutathione's role:**
- BSP-GSH formation highlights the crucial role of glutathione in detoxification.
- Researching the formation and breakdown of BSP-GSH helps elucidate the mechanisms underlying glutathione's antioxidant and protective functions.
- This information is valuable for studying various diseases related to oxidative stress and glutathione depletion.

4. **Developing new drugs:**
- Understanding the factors affecting BSP-GSH formation can guide the development of new drugs that target specific metabolic pathways.
- By modifying the chemical structure of BSP or other compounds, researchers can create drugs that are more effectively metabolized or have specific effects on the liver.

**In conclusion, (sulfobromophthalein)glutathione conjugate is a valuable tool for researchers studying liver function, drug metabolism, and the role of glutathione in detoxification. Understanding this conjugate provides crucial insights for drug development, disease diagnosis, and therapeutic interventions.**

Cross-References

ID SourceID
PubMed CID162696
MeSH IDM0109505

Synonyms (7)

Synonym
(sulfobromophthalein)glutathione conjugate
glycine, n-(n-l-gamma-glutamyl-l-cysteinyl)-, mixt. with disodium 3,3'-(4,5,6,7-tetrabromo-3-oxo-1(3h)-isobenzofuranylidene)bis(6-hydroxybenzenesulfonate)
glutathione-sulfobromophthalein conjugate
bsp-sg
52682-84-5
DTXSID70200651
disodium;(2s)-2-amino-5-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid;2-hydroxy-5-[4,5,6,7-tetrabromo-1-(4-hydroxy-3-sulfonatophenyl)-3-oxo-2-benzofuran-1-yl]benzenesulfonate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (50.00)18.7374
1990's6 (42.86)18.2507
2000's1 (7.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.37 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]